Gender differences in acute coronary syndrome in Arab Emirati women--implications for clinical management

Angiology
Abdulla ShehabAbdulla Alnaeemi

Abstract

Gender differences exist in many aspects of acute coronary syndrome (ACS), including presentation and delay in diagnosis and treatment. The aim of the study was to evaluate gender-related differences in ACS patients in the United Arab Emirates (UAE). We analyzed a subset (n = 1697) of the Gulf Registry of Acute Coronary Events (Gulf RACE) data collected in 2007 of patients with ACS from 18 UAE hospitals. Women were significantly older (mean age: 64.0 ± 12.4 years for females and 50.9 ± 10.6 years for males, P < .001), more often had cardiac risk factors and were significantly less treated with β-blockers and reperfusion therapy. The adjusted mortality rate of women was 4.6% versus 1.2% in men (P < .001). Heart failure was higher in females compared with men (24.6% vs 12.5%; P < .001). Reasons for the high in-hospital mortality in women need to be investigated further.

References

May 18, 1979·JAMA : the Journal of the American Medical Association·K J ArmitageR A Bass
Sep 3, 1994·BMJ : British Medical Journal·K W ClarkeJ R Hampton
Nov 22, 2002·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Abdulrahman O Musaiger
Jun 25, 2004·American Heart Journal·Harshida PatelInger Ekman
Dec 4, 2004·Internal Medicine·Ken KanamasaUNKNOWN South Osaka Acute Coronary Syndrome Study Group
Aug 6, 2005·International Journal of Cardiology·Elisabeth PerersMarianne Hartford
Jul 11, 2006·The American Journal of Cardiology·Tobias HeerUNKNOWN ACOS Investigators
Oct 6, 2009·The American Journal of Cardiology·Ayman El-MenyarJassim Al Suwaidi
Nov 6, 2009·European Journal of Heart Failure·Alawi A Alsheikh-AliUNKNOWN Gulf RACE Investigators
Nov 26, 2009·European Heart Journal·Anders HvelplundSteen Z Abildstrøm
Jun 16, 2010·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S W NgB M Popkin
Jan 5, 2011·The American Journal of Cardiology·Fabrizio D'AscenzoImad Sheiban
Apr 1, 2011·Current Pharmaceutical Design·Marcin BarylskiMaciej Banach
Jan 1, 2011·Journal of the Saudi Heart Association·Kadhim SulaimanIbrahim Al-Zakwani

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy

Software Mentioned

Statistical Package for Social Sciences ( SPSS )

Related Concepts

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.